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ABSTRACT  A glycoprotein (PAS IV) of apparent Mr 76,000 was purified from bovine milk-fat- 
globule  membrane  and  partially  characterized.  PAS  IV contained  mannose,  galactose,  and 
sialic acid as principal sugars (~5.3% total carbohydrate [wt/wt]) and existed in milk in at least 
four isoelectric variants.  The glycoprotein appeared to be an integral  membrane  protein by 
several criteria. PAS IV was recovered in the detergent phase of Triton X-114 extracts of milk- 
fat-globule membrane at room temperature. When bound to membrane, PAS IV was resistant 
to digestion  by a number of proteinases,  although after solubilization with  non-ionic deter- 
gents, the protein was readily degraded. Amino acid analysis of the purified protein revealed 
a  high  percentage  of  amino  acids  with  nonpolar  residues.  The  location  of  PAS  IV  was 
determined in bovine tissues by using immunofluorescence techniques. In mammary tissue, 
PAS IV was located on both the apical  surfaces of secretory epithelial cells and endothelial 
cells  of capillaries.  This glycoprotein  was  also  detected  in  endothelial  cells  of heart,  liver, 
spleen,  pancreas, salivary gland, and small intestine. In addition to mammary epithelial cells, 
PAS IV was also located in certain other epithelial cells, most notably the bronchiolar epithelial 
cells of lung. The potential usefulness of this protein as a specific marker of capillary endothelial 
cells in certain tissues is discussed. 
During lactation, milk triacylglycerols  are secreted from mam- 
mary epithelial cells in the form of discrete droplets coated 
with a  surface layer of membrane (2,  61).  This membrane 
layer, commonly referred to as the  milk-fat-globule mem- 
brane (MFGM), j is derived from the apical pole of secretory 
alveolar cells by a budding process in which intracellular lipid 
droplets are progressively enveloped with apical plasma mem- 
brane  (6,  7,  21).  Some  membrane  may  also  be  acquired 
directly from secretory vesicle membrane within the cell (77, 
78),  although the magnitude of the contribution to MFGM 
from this source remains controversial (21,  53). As may be 
expected, the cell-surface origin of MFGM is reflected in the 
enzyme and  lipid  composition of membrane  preparations 
isolated from milk. Typical plasma membrane components 
enriched in MFGM include sphingomyelin, 5'-nucleotidase, 
i Abbreviations used in this paper:  MFGM,  milk-fat-globule  mem- 
brane; PMSF, phenylmethylsulphonyl fluoride; TBS, Tris-buffered 
saline; TLCK, N-a-p-tosyl-L-lysine  chloromethyl ketone. 
phosphodiesterase, and alkaline phosphatase (14, 43, 44, 53). 
MFGM  thus  provides  a  convenient source  of membrane 
protein and lipid from a  specific epithelial cell type in  an 
heterogeneous population of cells. 
Separation of the proteins of MFGM from several species 
by SDS PAGE leads to the resolution of eight to ten major 
components (2,  14, 21, 23,  31, 46, 50,  52,  55,  61).  Two of 
these components,  xanthine oxidase and  butyrophilin, ac- 
count for nearly 50% of  the total protein detectable by staining 
gels with  Coomassie Blue (21,  40,  54-56).  Butyrophilin is 
firmly bound to MFGM and appears to be largely restricted 
to the apical plasma membrane of secretory epithelial cells 
(2 l, 31). Other glycoproteins that appear largely restricted to 
the apical surface include a highly sialylated protein with an 
Mr of over 400,000 in several species (references 4,  12, and 
20 and data in press)  and glycoproteins of Mr  100,000  and 
55,000 in the cow and guinea pig, respectively (unpublished 
data). 
In  contrast,  xanthine  oxidase is  present  throughout the 
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appears in higher concentrations towards the apical pole of 
these cells (40).  Secreted fat globules contain large amounts 
of xanthine oxidase in both a soluble and a membrane-bound 
form (11,  40,  54, 56). Xanthine oxidase is also present in a 
soluble form in capillary endothelial cells in mammary tissue 
and in other tissues appears largely restricted to this cell type 
(11, 40). 
MFGM  preparations from human,  cow, and guinea pig 
also contain a glycoprotein with an Mr of ~75,000-80,000 
(PAS  IV  of reference 55).  Approximately 5%  of the  total 
Coomassie Blue-positive protein of bovine MFGM is com- 
posed of this component (55). We have purified PAS IV to 
homogeneity and determined the distribution of this glyco- 
protein in bovine tissues by immunofluorescence microscopy. 
The antigen is concentrated on the apical surfaces of secretory 
epithelial  cells  in  mammary tissue  but  is  also  present,  in 
apparently  significant  amounts,  in  mammary  endothelial 
cells. In other tissues,  with some exceptions, PAS IV is re- 
stricted  to  capillary endothelial  cells  and  unlike  xanthine 
oxidase appears to be firmly bound to cellular membranes, a 
reflection of the protein's pronounced hydrophobic proper- 
ties.  Thus,  this  protein  serves as  a  convenient membrane 
marker for capillary cells  in certain tissues.  In this present 
communication, we describe the purification of PAS IV from 
bovine milk, the biochemical characterization of this protein, 
and the determination of its distribution  in bovine tissues 
using immunological procedures? Part of this work has been 
previously published in abstract form (27, 28). 
MATERIALS  AND  METHODS 
Materials:  Aprotinin,  6-amino-n-caproic  acid, phenylmethylsulphonyl 
fluoride (PMSF), n-propyl gallate, Histopaque,  BSA, DEAE-cellulose, N-c~-p- 
tosyI-L-lysine chloromethyl  ketone (TLCK), neuraminidase  (type X), pronase 
(type XIV), papain (type IV), trypsin (type XI), and pepsin were obtained from 
Sigma Chemical Co. (St. Louis, MO). Chymotrypsin was purchased from ICN 
Pharmaceuticals,  Inc. (Cleveland, OH) and amino acid standards  were from 
the  Pierce Chemical  Co.  (Rockford,  IL).  Triton  X-100  and  X-II4,  SDS, 
ampholines,  acrylamide,  nitrocellulose paper, and M, protein  standards were 
obtained  from Bio-Rad  Laboratories  (Richmond,  CA). Ultrodex  resin  was 
purchased from LKB Instruments, Inc. (Gaithersburg, MD). Concanavalin A/ 
Agarose was purchased from E-Y Laboratories, Inc. (San Mateo, CA) and 125I- 
labeled goat anti-rabbit  IgG was from New England Nuclear (Boston,  MA). 
Freund's complete adjuvant,  V-8 proteinase, rabbit antimouse IgG, fluorescein 
isothiocyanate-conjugated rabbit anti-guinea pig IgG and guinea pig antibodies 
to bovine prekeratin were obtained from Miles Laboratories, Inc. (Elkhart, IN). 
Fluorescein isothiocyanate-conjugated  avidin and biotinylated goat anti-rabbit 
IgG and horse anti-mouse  lgG were purchased from Vector Laboratories, Inc. 
(Burlingame, CA). Rabbit  antibody  to human factor VIII-associated protein 
was obtained  from Calbiochem-Behring  Corp. (La Jolla, CA) and cyanogen- 
bromide-activated  Sepharose 4-B was from Pharrnacia Fine Chemicals (Pisca- 
taway, N  J). O.C.T. compound for embedding frozen specimens was from Lab- 
Tek Div., Miles Laboratories, Inc. (Naperville, IL). 
Preparation  of  Membrane  and  Milk  Fractions:  "Plasma- 
lemma-enriched"  membrane fractions from bovine mammary tissue obtained 
from Holstein cows at slaughter were prepared by modification of a procedure 
described by Huggins et al. (37). Mammary tissue was homogenized for 20 s in 
4 vol (wt/vol) of ice-cold homogenization  buffer (20 mM Tris-HCI, pH 7.4, 
containing  0.25 M  sucrose) using a  Sorvall Omni-mixer (E.  1.  DuPont de 
Nemours & Co.,  Inc.,  Sorvall Instruments Div.,  Newtown, CT)  at a  speed 
setting of 5. The homogenate  was filtered through four layers of cheesecloth 
and centrifuged for 10 min at 750 g. The resulting membrane pellet was then 
resuspended  and  homogenized  in  1 vol  of homogenization  buffer  with  a 
Dounce, type A, homogenizer, and centrifuged as above. After centrifugation, 
2 Throughout the text,  for convenience, we refer to this antigen as 
one protein, regardless of tissue location. This assumes that PAS IV 
is essentially the product of one gene or closely related genes. 
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the supernatant  was recentrifuged for 7.5  min at 32,000 g, and subsequently 
for  75  min at  100,000 g.  The  final  membrane pellet was resuspended  in 
homogenization  buffer, adjusted to a final sucrose concentration  of 40% (wt/ 
vol), and centrifuged for 4 h at  100,000 g under a sucrose gradient, prepared 
by overlaying the sample with 9 ml each of 36, 32, and 0.9% (wt/vol) sucrose 
in 20 mM Tris-HC1 buffer, oH 7.4. The membrane fraction that collected at 
the 32/0.9% interface was designated as the "plasmalemma-enriched"  fraction. 
The alkaline phosphatase activity of this fraction was enriched  16- to 17-fold 
over the activity in the total homogenate. Similar preparations from lactating 
guinea pig mammary tissue have been extensively characterized. Activities of 
the following enzymes were significantly enriched over total  homogenates  in 
these fractions:  5'-nucleotidase  (17-fold), alkaline  phosphatase  (14-fold), ga- 
lactosyl transferase (19- to 20-fold), and uridine diphosphatase (10-fold). Prep- 
arations were devoid of the mitochondrial  marker enzyme, succinate/iodoni- 
trotetrazolium  reductase. 
Crude  microsomal  membrane fractions were also prepared  from lactating 
mammary glands. Tissue was minced with scissors and homogenized in 3 vol 
(wt/vol)  of Tris-buffered saline (TBS; 10  mM Tris-HCI, pH  7.4, containing 
0.15 M NaC1, 5 mM 6-amino-n-caproic  acid, 0.5 mM PMSF, and aprotinin, 
650 kallikrein inhibitor  units [iu]/ml) in a Sorvall Omni-mixer  at maximum 
speed for 30 s at 4"C. Homogenates were centrifuged at 1,000 g for 10 rain and 
the resulting supernatants  were further centrifuged for 10 rain at 10,000 g. The 
10,000-g supernatants  were then centrifuged at 95,000 g for 1 h and the final 
membrane pellet designated "crude microsomal membrane fraction." 
Bovine MFGM  and soluble Triton  X-100 extracts were prepared as previ- 
ously described (55). The soluble fraction of milk was prepared by centrifuging 
skim milk at 90,000 g, for 90 min at 4°C. The clear aqueous supernatant  was 
retained and designated "soluble whey fraction." Both the thin layer of  residual 
fat and the white casein pellet were discarded. 
To resolve adsorbed, peripheral proteins  from integral membrane protein, 
we resuspended  membrane fractions (<0.5  mg protein/ml) at 0*C in 0.1  M 
Na2CO3 (24, 35) and subjected them to ultrasound  a total of four times, every 
l0 rain for 30-s periods. The suspensions were then centrifuged at  114,000 g 
for 1 h at 4"C and membrane pellets were resuspended in  ~0 mM Tris-HCI 
buffer, pH 7.4. 
Purification of PA5 IV:  PAS IV was purified by a four-step procedure 
involving proteinase treatment  of bovine MFGM, solubilization of the protein- 
ase-resistant proteins  in Triton X-100, DEAE-cellulose chromatography,  and 
adsorption to and elution from concanavalin A/Agarose. 
Bovine MFGM (2 mg of membrane protein/ml; 0.5-1  gram total protein) 
was incubated at pH 6.2 in 5 mM cysteine containing 2 mM EDTA and papain 
(0.75 IU/mg membrane protein) for 2 h at 37"C. Proteinase inhibitors (0.4 mM 
PMSF and 0.04 mM TLCK, final concentrations)  were then added  and  the 
mixture was centrifuged at 96,000 g for I h at 4"C (for data on the inhibition 
of papain with these compounds, see reference 75), The membrane pellet was 
resuspended in  10 mM Tris-HCI buffer, oH 7.5, containing  0.02 mM PMSF 
and 0.02 mM TLCK and dialyzed at 4"C overnight against 4 liters of the same 
mixture.  The protein  composition  of the  treated  membrane at this  stage is 
compared with untreated MFGM in lanes 1 and 2 of Fig. 1. Following dialysis, 
the  papain-digested  membrane suspension  was extracted  with  1%  (vol/vol) 
Triton  X-100 as described (55) but with the addition  of 0.4 mM TLCK, and 
the solubilized proteins were collected by centrifugation  at 100,000 g for 2 h. 
Triton  X-100 extracts contained  a  fraction  of all  the major  proteins  in the 
proteinase-treated  membrane (compare  Fig.  1,  lanes  2  and  3)  including  a 
substantial enrichment  in PAS IV over the untreated  membrane.  The solubi- 
lized proteins were then fractionated on DEAE-cellulose that had been previ- 
ously equilibrated with a mixture of 10 mM Tris-HCI buffer, pH 7.5, and 0.5% 
(vol/vol) Triton X-100. After washing the column of ion-exchange resin (2 × 
30 cm) with several volumes of equilibration  buffer, PAS IV was eluted with a 
0-100 mM linear gradient of  NaC1 in 10 mM Tris-HC1  buffer, pH 7.5. Collected 
fractions were analyzed by SDS PAGE and samples enriched in PAS IV (eluted 
between 30 and 50 mM NaCI) were pooled (Fig. 1, lane 4) and adsorbed onto 
a column ofconcanavalin  A/Agarose (I.5 ×  10 cm). At least 5 column volumes 
of 10 mM Tris-HCI buf]'er, oH 7.5, containing 0.2 M NaCI and 0.5% (vol/vol) 
Triton  X-100 were passed through the column and PAS IV was eluted with a 
solution of 0.4 M a-methylmannoside  in 50 mM Tris-HCI buffer, pH 7.5 (Fig. 
1, lane 5). This final step served to concentrate the protein fractions and remove 
minor contaminants with molecular weights just below that of  PAS IV. Purified 
protein  samples were dialyzed against TBS or other appropriate  buffers and 
stored at -20"C. Yields of PAS IV were at least  10%  of the theoretical  yield 
assuming a 20-fold purification from untreated  MFGM. 
Preparation of Monoclonal and Affinity-purified  Polyclonal 
Antibodies to PAS IV:  We isolated two hybridoma cell lines, designated 
E-I and E-3, by fusing spleen cells from mice immunized  with purified PAS 
IV and SP-2/0 myeloma cells (71 ). The positive hybrids were cloned four times 
and grown as ascites tumors in BALB/c mice. Specificity of these monoclonal antibodies  was determined  by solid-phase immunoassay and immunoaffinity 
chromatography.  Full details ,of these procedures will be published separately 
(D. E. Greenwalt, V. G. Johnson, and I. H. Mather, manuscript in preparation). 
All the work reported in this present paper was performed with antibody from 
the E- 1 cell line which is designated "E- 1 monoclonal antibody." 
Polyclonal rabbit antibody  to PAS IV was prepared by using the  purified 
protein  (see above) as immunogen. Purified  PAS IV was separated  by SDS 
PAGE and the monomerie form of the protein  was excised from the gel slab. 
The pieces of polyacrylamide were mashed with a glass homogenizer and mixed 
with Freund's complete adjuvant  in a  1:1  ratio (vol/vol). Approximately  100 
vg of protein  was injected once a month, and after at least three  injections, 
antisera  were  collected  by  standard  procedures.  Affinity-purified antibodies 
were obtained  from this serum by adsorption  to and elution  from PAS IV 
immobilized on Sepharose 4-B. Rabbit antisera (10 ml) was dialyzed overnight 
at 4"C against 50 mM Tris-HCl buffer, pH 7.4, containing  0.15 M NaCl. The 
dialyzed  serum was then  fractionated  on  a  column  of PAS  IV bound to 
Sepharose 4-B, prepared  by covalently linking  5 mg of purified antigen to  1 
gram (dry wt) of cyanogen-bromide-activated  Sepharose 4-B. After washing 
the  column with  the  above  Tris-HCl  dialysis buffer,  we eluted  specifically 
bound antibodies with 3 M NaSCN and dialyzed them overnight at 4"C against 
4 liters of the same buffer. The final yield of affinity-purified antibody was ~ 5 
mg of protein,  1.5 mg/ml. Dilutions  referred to in the text are from the stock 
solution of "undiluted  antibody." 
Partitioning  of  MFGM  Proteins  in  Triton  X-774  Solu- 
tions:  Bovine MFGM  (l  mg membrane protein/ml, final concentration) 
was extracted with Triton  X-114 (1%, vol/vol) in 50 mM Tris-HC1 buffer, pH 
7.4, containing  0.15 M NaCI,  1 mM EGTA,  l  mM 6-amino-n-caproic  acid, 
aprotinin  (650 iu/ml), and 0.5 mM PMSF. After being stirred for 20 rain at 
0°C, the  mixture  was incubated  without  stirring for an additional  20 rain at 
0°C and then centrifuged at  100,000 g for 1 h. The supernatant fraction was 
then warmed to 30°C and centrifuged at 2,000 g for 15 min. The aqueous and 
detergent phases were collected separately and washed either with Triton X- 
l 14 ( 1% [vol/vol], final concentration),  or with a  l 0-fold excess of cold TBS, 
respectively. After a second condensation  cycle, the two phases were made up 
to equal volumes with TBS. Methods were based on the procedures of Bordier 
(9). 
Degradation of MFGM with  Enzymes:  Preparations  of bovine 
MFGM  (1  mg membrane protein/ml) were incubated  with the proteinases 
trypsin, chymotrypsin,  papain, pronase, and pepsin for l h at 37°C. Solutions 
used for these proteinases were as follows: 40 mM Tris-HCl, pH 7.8, containing 
50 mM CaC12 (trypsin), 40 mM Tris-HCl, pH 8.1, containing  l0 mM CaC12 
(chymotrypsin), 5 mM cysteine, pH 6.2, containing  2 mM EDTA (papain), 60 
mM Tris-HCl, pH 7.6, containing  0.39 M NaC1, I l mM KCI, 5 mM CaCl2, 
and 3.6 mM MgSO4 (pronase), and 6 mM HCI (pepsin). After digestion, the 
samples were centrifuged at 100,000 g for 1 h. The treated membrane fractions 
were then resuspended in  l0 mM Tris-HCl buffer, pH 7.4, and aliquots were 
prepared  for SDS PAGE.  MFGM  was desialylated by treatment  with neura- 
minidase (0.01 IU/mg membrane protein)  for 1 h at 37°C in 50 mM sodium 
acetate buffer, pH 5.1. 
SD5 PAGE and Isoelectric Focusing:  SDS PAGE and analytical 
and preparative  isoelectric focusing were performed  as previously described 
(55).  Proteins  were  either  stained  with  the  periodic  acid/Schiff  reagent  or 
Coomassie Blue (l 9, 55). Determination  of the molecular weights of proteins 
by SDS PAGE was as described (70), using the following proteins as standards: 
myosin  (200,000), ~-galactosidase (116,000), phosphorylase  b (92,500),  BSA 
(66,500), ovalbumin  (45,000), carbonic  anhydrase  (31,000), soybean trypsin 
inhibitor (21,500), and lysozyme (14,400). 
Immunoblotting Procedures:  Protein  samples were separated by 
SDS PAGE and electrophoretically transferred  to nitrocellulose paper, essen- 
tially as described  by Towbin  et al. (72). The nitrocellulose  paper was then 
rinsed sequentially with 0.1% (vol/vol) Triton X-100 in TBS (without protein- 
ase inhibitors)  for  1 h and overnight  with 2%  (wt/vol)  BSA in 2%  (wt/vol) 
BSA/TBS. Affinity-purified rabbit antibodies to PAS IV, diluted  1:200 in 2% 
(wt/vol)  BSA/TBS,  were  then  incubated  with  the  paper for  l  h  and  the 
nitrocellulose was sequentially treated as follows: 0.5 % (vol/vol) Triton X- 100/ 
TBS, 30 mira 0.5  M NaCI/TBS,  30 min; TBS, 30 min; 0.1% (wt/vol)  BSA/ 
TBS, 30 min: 12~I-labeled goat anti-rabbit  lgG (~2/~Ci)  in 2% (wt/vol) BSA/ 
TBS, 2 h: 0.1% (wt/vol) BSA/TBS, 30 min; 0.1% (vol/vol) Triton X-100/TBS, 
30 mira 0.5% (vol/vol) Triton X-100/TBS,  30 rain; 0.5 M NaCI/TBS, 30 min; 
and TBS, two changes, 30 min each. Preimmune serum was used in place of 
affinity-purified rabbit antibodies in control experiments. 
Immunofluorescence  Microscopy:  For  immunolocalization 
studies, tissue was obtained  from the Beltsville Agricultural  Research Center 
abattoir  (Beltsville, MD), from Holstein cows at slaughter. Tissue was either 
frozen in 2-methylbutane  cooled in liquid nitrogen and embedded  in O.C.T. 
compound or fixed with "methacorn" (60% [vol/vol] methanol, 30% [vol/vol] 
chloroform,  and  10%  [vol/vol]  acetic acid) and embedded  in paraffin  (74). 
Frozen tissue was sectioned with a cryostat/microtome  into 5-ttm-thick sec- 
tions, air-dried, and fixed in acetone at -20°C for 7 min. Paraffin-embedded 
tissue was cut  into 7-ttm-thick sections and dewaxed in xylene and ethanol. 
Blood samples were obtained from the tail vein and lymphocytes were isolated 
according to the procedure of B6yum (10). 
A similar staining protocol was used for all sections whether frozen or fixed 
in methacorn.  Blood cells were stained in suspension  using 50-#1 aliquots of 
antibody contained in the wells of  96-well plastic plates. Samples were incubated 
with undiluted hybridoma culture supernatant  or a 1:50 dilution of  the afffinity- 
purified rabbit antibodies to PAS IV in TBS that contained  1% (wt/vol) BSA. 
Preimmune serum or culture  medium was used in control experiments. After 
30 min at room temperature  the slides were washed three times in TBS. Blood 
cells were also washed three times by repeated centrifugation at 1,500 g for 15 
min and resuspension in TBS. Samples were then incubated  with biotinylated 
horse anti-mouse  IgG (4.3 mg/ml, stock solution) at a  1:100 dilution in TBS/ 
1% (wt/vol)  BSA for another 30 min. The samples were washed three  more 
times in TBS and incubated with fluorescein isothiocyanate-conjugated avidin 
at a 1:100 dilution of the stock solution (5.0 mg/ml) in TBS/I% (wt/vol) BSA 
for 30  min.  All slides were finally washed three  times in  TBS and once  in 
distilled water, and the specimens were mounted in glycerol containing  5% 
(wt/vol)  n-propyl  gallate to prevent  photobleaching  of the fluorescein  (26). 
Blood cell suspensions were directly mounted on microscope slides. Specimens 
were examined  with a Leitz Dialux microscope equipped with an H filter for 
wide band blue light excitation. 
Electron Microscopy:  MFGM samples for electron microscopy were 
fixed in 2.5% (wt/vol) glut,aldehyde in 50 mM sodium cacodylate buffer, pH 
7.2, containing  50 mM KCI, 2.5 mM MgC12, and 1.5 mM CaC12 and stained 
with 2%  (wt/vol)  OsO4 for  1 h and 0.5% (wt/vol)  uranyl  acetate  for  12  h. 
Specimens were dehydrated  in a graded series of acetone  solutions  and em- 
bedded in Epon 812. Sections (silver grade) were stained with uranyl acetate 
and lead citrate. 
Analytical Techniques:  For amino acid analysis, purified PAS IV 
was hydrolyzed in 6 N  HCI under nitrogen  at  110*C for 24, 48,  and  72  h. 
Amino acids were analyzed on a model JLC-6AH JOEL amino acid analyzer. 
Carbohydrates  were analyzed  by gas/liquid  chromatography  and mass spec- 
FIGURE  1  Analysis by SDS PAGE of fractions of PAS IV at various 
stages of  purification.  Samples were  separated  in  10%  (wtJvol) 
polyacrylamide (1.5-mm  thickness) as follows: lane I, unfraction- 
ated MFGM; lane 2,  membrane fraction following digestion with 
papain; lane 3, papain-digested proteins solubilized in Triton X-100; 
lane 4, soluble fraction after DEAE-cellulose chromatography; lane 
5,  PAS IV after further purification by affinity chromatography on 
concanavalin A/Agarose.  Proteins  were  stained  with  Coomassie 
Blue. Mr markers from top to bottom of the gel were as follows: 1, 
myosin (200,000); 2, ~-galactosidase (116,000); 3, phosphorylase b 
(92,500);  4,  BSA (66,500);  and  5,  ovalbumin (45,000).  PAS  IV is 
denoted by single arrowheads and traces of a dimeric form of PAS 
IV by double arrowheads in lane 5. 
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method of Aminoff  (1), after the samples were hydrolyzed  in 0.025 N H2SO4 
for 1 h at 80"C. Protein was analyzed  by the method  of  Lowry  et at. (49) or, in 
the presence of Triton X-100, as described by Peterson (63). In either case, 
BSA was used as a standard. Alkaline phosphatas¢ was assayed as previously 
described using  p-nitroohcnyl  phosphate  as substrate (55). 
RESULTS 
Digestion of MFGM with Proteinases and 
Preparation of PAS IV 
PAS  IV  was  not degraded  when  preparations  of bovine 
MFGM were extensively digested with the proteinases trypsin, 
chymotrypsin, or papain (see example for papain in Fig.  1, 
lane 2). Incubation of membrane with pronase led to partial 
degradation of PAS IV, whereas digestion with pepsin, at low 
pH, resulted in the complete degradation of all MFGM pro- 
teins.  After  solubilization  of PAS  IV  with  detergents,  the 
protein was degraded by all of the above enzymes and V-8 
proteinase from Staphylococcus aureus (not shown). 
PAS IV does not appear to be a  component of the cyto- 
plasmic coat of MFGM (21, 23, 77-79). Under conditions in 
which PAS IV remained associated with MFGM, this protein- 
aceous coat was completely removed by treatment with pro- 
teinases (e.g., papain, Fig. 2). 
The resistance of membrane-bound PAS IV to proleinase 
digestion led to a purification procedure for this protein, the 
first  step  of which  was  digestion  of the  major proteins  of 
MFGM  with  papain  (Fig.  1,  lanes  1  and  2).  Proteinase- 
resistant proteins were then solubilized in non-ionic detergent 
and  PAS IV was purified from the soluble extracts by ion- 
exchange  and  lectin-affinity  chromatography.  Details  of a 
representative purification  procedure are given in  Materials 
and Methods and summarized in Fig. 1. 
Analysis of purified PAS IV by SDS PAGE showed a single 
major band  of protein  that  stained  with  both  the  periodic 
acid/Schiff reagent and Coomassie Blue (single arrowheads, 
Fig.  1).  Traces of a  second component with an Mr exactly 
twice  that  of the  principal  component  were  also  evident 
FtGURE 2  Electron microscopy of bovine MFGM before and after treatment with papain. MFGM (1 mg of membrane protein/ 
ml) was incubated with papain (1.25 IU/mg of membrane protein), and samples of the digested membrane and untreated MFGM 
were processed for electron microscopy.  (a) MFGM before treatment with papain. (b) MFGM after treatment with papain. Note 
the fuzzy 'cytoplasmic' coat material in a (arrowheads) is completely removed by papain treatment in b, leaving an uncoated 
bilayer membrane. Bars, 0.1 ~,m. (a) x  105,000; (b) x  135,000. 
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major and minor components were compared by SDS PAGE 
and immunoblotting techniques, using rabbit antibody to the 
PAS IV monomer. Almost identical patterns of immunolog- 
ically reactive peptides were obtained, which indicates that 
the minor component of high Mr is most probably a dimeric 
form of PAS IV, which is resistant to disaggregation with SDS 
and thiol reducing agents (data not shown). 
Physical and Chemical Characterization of PAS IV 
The mobility of PAS IV during SDS PAGE was compared 
with a set of protein standards (see Materials and Methods), 
in 6, 8,  10, and  15 % (wt/vol) polyacrylamide gels. Apparent 
molecular  weights  were  estimated  to  be  78,500,  76,500, 
76,000, and 75,500, respectively. The asymptotic minimum 
Mr for PAS IV was therefore estimated to be 76,000. 
At least four variants of PAS IV were resolved by analytical 
isoelectric focusing, with apparent isoelectric points of 7.80, 
7.95,  8.15,  and 8.50.  When PAS IV was treated with neura- 
minidase and subjected to preparative electrofocusing in flat- 
beds of Ultrodex (55),  there was a  shift of at least one pH 
unit, in the range of isoelectric points, towards the basic end 
of the pH gradient. 
PAS IV appeared to have pronounced hydrophobic prop- 
erties. Removal of  detergent from preparations of  the purified 
protein, by nonpolar adsorption chromatography, led to com- 
plete precipitation  of PAS  IV  from  solution.  The  protein 
remained firmly bound to MFGM after treatment of isolated 
preparations with Na2CO3 solutions at high pH (Fig. 3, lanes 
1 and 2). Previous work has shown that this procedure effec- 
tively removes loosely bound and peripheral membrane pro- 
teins (24, 35). PAS IV was also recovered from the detergent 
phase after soluble Triton X- 114 extracts of bovine MFGM 
were warmed above the cloud point (Fig.  3, lanes 3 and 4). 
In contrast, the major glycoprotein of high Mr (double arrow- 
heads in Fig. 3, lanes 1 and 4) was recovered from the aqueous 
supernatant. Other membrane glycoproteins were distributed 
between both the aqueous and detergent phases.  Similar re- 
sults were obtained with Triton X-114-solubilized proteins 
from human MFGM (Fig.  3, lanes 5 and 6) and guinea pig 
MFGM (data submitted for publication). 
The  hydrophobic  nature  of PAS  IV  was  confirmed by 
amino acid analysis of the purified protein (Table I). At least 
50% of the amino acids have nonpolar residues and a further 
20% have side chains with uncharged polar groups at neutral 
pH. The protein is also characterized by a  low level of the 
sulphur-containing amino  acids,  cystcine and  methionine, 
and a  high percentage of the branched chain amino acids, 
valine, leucine, and isoleucine. The hydrophobicity index of 
PAS IV was  estimated to be  1,174,  which implies that the 
protein has a pronounced hydrophobic character (see Discus- 
sion).  Approximately 5.3%  of the glycoprotein is composed 
of carbohydrate on a weight basis.  The principal sugars  de- 
tected were mannose, glucose, galactose, and sialic acid (Table 
II). Since the quantity of material available for analysis was 
near the limits of sensitivity, the  recorded values are only 
approximate. 
Determination  of the Distribution of PAS IV in 
Mammary Tissue and Milk Using Immunoblotting 
Procedures 
The distribution of PAS IV in various fractions of milk and 
FIGURE 3  Analysis by SDS PAGE  of MFGM proteins after treatment 
with Na2CO3  solutions  and after partitioning  in Triton X-114. MFGM 
was extracted with 0.1 M Na2CO3  as described (24, 35) and samples 
of the insoluble residue (lane I) and the Na2CO3  supernatant (lane 
2) were separated in 6% (wt/vol) polyacrylamide  (3-ram thickness). 
Bovine and human MFGM were also extracted in Triton X-114 at 
0°C and the soluble extracts were warmed to 30°C. After phase 
separation, the aqueous and detergent layers were collected and 
further treated as described in  Materials  and Methods. Samples, 
separated  by SDS  PAGE, are  as follows: lane 3,  bovine MFGM, 
detergent phase; lane 4,  bovine MFGM, aqueous phase; lane 5, 
human MFGM, detergent phase; lane 6, human MFGM, aqueous 
phase. All samples were stained with the periodic acidlSchiff re- 
agent. PAS IV in bovine and human MFGM is indicated by single 
arrowheads (lanes 1, 3, and 5). Major glycoproteins of high Mr and 
with  pronounced  hydrophilic  properties  in  bovine and  human 
MFGM are indicated by double arrowheads (lanes 1, 4, and 6). 
TABLE I 
Amino Acid Composition of PAS IV 
Residues 
per 
Mole  76,000 
Amino acid  percent  Mr 
Nonpolar 
Alanine  5.8  49.5 
Glycine  6.7  67.8 
Isoleucine  8.2  47.5 
Leucine  9.5  55.0 
Methionine  1.0  5.1 
Phenylalanine  6.6  30.4 
Proline  5.2  34.3 
Tryptophan  ND  -- 
Valine  9.5  61.7 
Polar (with uncharged polar groups) 
Cysteine  1.8  11.3 
Serine*  7.3  52.8 
Threonine*  8.4  53.6 
Tyrosine  3.8  15.9 
Polar (with charged groups) 
Aspartic acid (+ asparagine)  7.7  44.0 
Glutamic acid (+ glutamine)  3.4  17.6 
Arginine  2.7  11.8 
Histidine  5.0  24.5 
Lysine  7.6  39.5 
ND, not determined. 
* Values for serine  and threonine were  calculated  by extrapolating  to zero 
time; values  obtained  from samples  hydrolyzed  for 24, 48, and 72 h. 
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noblotting techniques. Samples of MFGM, crude microsomal 
membranes,  and  Na2CO3-washed  plasmalemma-enriched 
membranes from lactating mammary tissue and a sample of 
the  soluble whey fraction  of milk  were  separated  by SDS 
PAGE. The separated proteins were electrophoreticaUy  trans- 
ferred to nitrocellulose paper and immunoreactive proteins 
were detected by using affinity-purified polyclonal antibody 
to PAS IV and  125I-labeled goat anti-rabbit IgG.  Proteins of 
the  same  Mr  as  PAS  IV  were  detected in  MFGM,  crude 
microsomes, and the plasmalemma-enriched fraction (Fig. 4, 
lanes I, 3,  4, and 6-8).  An additional prominent immuno- 
reactive protein of approximate Mr 80,000-85,000 was  de- 
tected in the plasmalemma-enriched fraction (asterisk  in Fig. 
4,  lane  6).  Traces of a  second  immunoreactive protein  in 
TABLE  II 
Sugar Composition of PAS IV 
mole/mole 
Sugar  #g/mg protein  protein* 
Galactose  20.2  8.6 
Mannose  18.6  7.9 
Glucose  [23.2]  -- 
N-Acetylglucosamine*  ?  ? 
N-Acetylgalactosamine  0  0 
Sialic acid  14.7  3.65 
* Assuming an M, of 76,000. 
* A  peak of mate, rial  at  the correct  retention  time for N-acetylglucosamine, 
but with an incorrect  mass  spectrum, was detected. 
MFGM and the plasmalemma-enriched fraction of exactly 
double the Mr of PAS IV (dots in Fig. 4, lanes 4 and 6) were 
also noted. This second component was  assumed to be di° 
meric PAS IV, present in the SDS-solubilized extracts (Fig. 
1). Cross-reaction with this protein was ~ot due to the presence 
of  trace impurities in our PAS IV preparations used for raising 
antibodies, because we used monomeric PAS IV, separated 
by SDS PAGE as immunogen (see Materials and Methods). 
In contrast to the above results,  immunologically similar 
proteins to PAS IV were not detected in the soluble whey 
fraction of milk (Fig. 4, lane 5). Prominent glycoproteins in 
bovine whey of Mr ~70,000-80,000 include secretory com- 
ponent,  lactoferrin,  and  lactoperoxidase (13,  29,  30).  We 
confirmed that PAS IV is not related to secretory component 
by immunodiffusion in  Agarose  gels  and  immunoblotting 
techniques with  purified bovine secretory component and 
specific  antibody to  this  protein.  Nor was  the  amino  acid 
composition  of PAS  IV  (Table I)  found  to  be  similar  to 
secretory  component (30), lactoferrin, or lactoperoxidase (29). 
Proteins of approximately the same Mr as bovine PAS IV 
were also present in human and guinea pig MFGM (Fig. 4, 
lanes 9-11). Both the human and guinea pig proteins cross- 
reacted weakly with the antibody to bovine PAS IV, which 
indicates that a similar protein is present in the milk of all 
three species (Fig. 4, lanes 12-14). 
These immunoblots established the specificity of our affin- 
ity-purified polyclonal antibody preparations and confirmed 
that PAS IV is a distinct constituent of MFGM. The obser- 
vation that an immunoreactive protein of slightly higher Mr 
FIGURE  4  Distribution of  PAS  IV  in  mammary tissue  and  milk, determined by SDS  PAGE and  immunoblotting techniques. 
Samples were separated by SDS PAGE and the proteins were electrophoretically transferred to nitrocellulose paper. PAS IV-like 
proteins were localized by using affinity-purified polyclonal antibody. Duplicate control gels were stained with Coomassie Blue. 
(a) Lanes 1 and 4,  bovine MFGM; lanes 2 and 5, soluble whey fraction; lane 3 and 6, Na2CO3-washed plasmalemma-enriched 
fraction; lanes 7 and 8, crude microsomal fraction. Lanes 1-3 and 7 are Coomassie  Blue-stained gels and lanes 4-6 and 8, the 
corresponding immunoblots. The Mr of PAS  IV in bovine MFGM is denoted by a single arrowhead and cross-reactive  proteins 
discussed  in the text by an asterisk and dots. (b) Lanes 9 and  /2, bovine MFGM; lanes  10 and  13, human MFGM and lanes  11 
and  14, guinea pig MFGM. Lanes 9-11 are Coomassie Blue-stained gels and lanes 12-14, the corresponding immunoblots. The 
Mr of PAS IV in bovine MFGM is denoted by a single arrowhead. 
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mammary tissue (Fig. 4, lane 6) raises the possibility that PAS 
IV  is  subjected  to  limited  proteolysis during  or  following 
secretion. 
Determination of the Distribution of PAS IV in 
Various Tissues Using Immunofluorescence 
Microscopy 
PAS IV was localized in various tissues  using immunoflu- 
orescence microscopy and both affinity-purified rabbit anti- 
bodies and monoclonal antibody E-1. Immunological deter- 
minants on PAS IV were detected with the affinity-purified 
rabbit antibodies using methacorn-fixed, paraffin-embedded 
specimens, and with the monoclonal antibody using acetone- 
fixed, frozen tissues. Neither antibody bound to PAS IV when 
conditions were reversed. Evidently both antibody prepara- 
tions recognize conformational determinants on the antigen 
that are destroyed by different fixation and embedding pro- 
cedures. 
In lactating mammary tissue, PAS IV was  detected with 
the  polyclonal rabbit  antibodies  on  the  apical  surfaces  of 
secretory epithelial cells (double arrowheads, Fig. 5 a). In view 
of the known origin of MFGM from the apical surfaces of 
secretory cells (2, 2 l, 61), this result was unsurprising. How- 
ever, significant immunofluorescence was also detected on 
cells underlying the secretory epithelium (single arrowheads, 
Fig.  5,  a  and  b)  with  both  rabbit  antibody (Fig.  5 a)  and 
monoclonal antibody E-I  (Fig.  5b).  With  the  monoclonal 
antibody, immunofluorescence staining of these basal  cells 
was more pronounced than staining of the apical surfaces of 
secretory epithelial  cells.  These immunoreactive cells  were 
identified as capillary endothelial cells by using antibody to 
factor VIII antigen as a cell-specific marker (39, 41). Adjacent 
frozen sections of lactating mammary tissue were incubated 
with either antibody to factor VIII antigen or monoclonal 
antibody E-1. The same cells were apparently stained with 
either antibody (Fig.  5, c and d). In contrast, myoepithelial 
cells  identified with  antibody to prekeratin (22),  were un- 
stained with either of our PAS IV antibodies (not shown). 
The  endothelial  location  of PAS  IV  was  confirmed by 
determining  the  distribution  of this glyeoprotein in  other 
tissues.  Prominent and specific immunofluorescence of cap- 
illary endothelial cells  was  seen  with  both  polyclonal and 
monoclonal antibodies to PAS IV in heart and the muscularis 
of small intestine, tissues in which endothelial cells are readily 
identified (Fig. 6, a and b). Other organs and tissues in which 
endothelial  cells  were  specifically  decorated with  PAS  IV 
antibody were liver (Fig. 6 c), spleen, salivary gland, pancreas, 
and the mucosae of small intestine. Monoclonal antibody E- 
l appeared consistently specific for endothelial cells and cross- 
reacted  in  some  tissues,  e.g.,  liver,  pancreas,  and  salivary 
gland, to which the rabbit antibody apparently did not bind 
(summarized in Table III).  The rabbit antibody also weakly 
stained epithelial cells  in  some tissues.  Occasional staining 
was detected on the apical surfaces of pancreatic acinar cells 
and the epithelial cells of intestinal crypts (Table III). 
Apart  from  mammary  gland,  the  only tissue  examined 
(Table III) that showed significant staining of epithelial cells 
with both antibodies was lung. Apical surfaces of lung bron- 
chioles were prominently and specifically  stained (Fig.  6d). 
Interestingly, the extensive capillary bed of lung showed.no 
reaction with either polyclonal or monoclonal antibody. The 
capillaries of brain and kidney were also unreactive. 
In  the  vascular  system,  where  PAS  IV  appeared  to  be 
restricted to the endothelial cells of capillaries,  no significant 
staining of large blood vessels was detected. Peripheral lym- 
phocytes and erythrocytes collected from individual blood 
samples of ten cows were also unstained by either antibody. 
DISCUSSION 
The presence of a  relatively basic glycoprotein in  MFGM, 
with an apparent Mr of 75,000-80,000, was recognized pre- 
viously by SDS PAGE and isoelectric focusing (46,  51,  52, 
55). This glycoprotein comprises ~5% of bovine MFGM on 
a weight basis (55), and our polyclonal rabbit antibodies show 
some cross-reaction with a similar glycoprotein in the human 
and guinea pig membranes. PAS IV remains associated with 
MFGM when membrane preparations are treated with 0.1 M 
Na:CO3 solutions at pH 11.5, conditions previously shown to 
remove a large proportion of loosely adsorbed and peripheral 
membrane proteins (24, 35). By several other criteria PAS IV 
is an integral membrane glycoprotein. Of the major proteins 
and glycoproteins routinely identified by SDS PAGE, PAS IV 
is the only component that is recovered in almost 100% yield 
from the detergent phase when total membrane extracts are 
partitioned in  Triton  X-114  solutions.  In  the  membrane- 
bound form, the glycoprotein is resistant to proteolysis under 
conditions that completely remove the cytoplasmic protein 
coat  material  routinely  seen  in  electron  micrographs  of 
MFGM.  However, when solubilized by various detergents, 
PAS IV is readily degraded by a variety of proteinases. These 
results  imply  that  PAS  IV  is  closely associated  with  the 
membrane lipid bilayer and is not a peripheral protein of the 
cytoplasmic coat or loosely adsorbed to the external mem- 
brane surface. The resistance of the membrane-bound form 
of this glycoprotein to exogenous proteinases has been noted 
previously, but without extensive comment (47, 52). 
The hydrophobic properties of PAS IV were confirmed by 
amino acid analysis of purified preparations. Amino acids 
with nonpolar residues, especially the branched chain acids, 
comprise a large proportion of the total. The hydrophobicity 
index (8,  59) of PAS IV was  estimated to be  1,174,  which 
compares  favorably with  other  well-characterized  integral 
membrane glycoproteins, e.g.,  1,120  and  1,185  for bovine 
rhodopsin and bacteriorhodopsin, respectively (8,  16). This 
index, which is obtained from the molar free energies for the 
transfer of individual amino acids from aqueous solution to 
organic solvent, is  correlated with  the overall hydrophobic 
character of proteins (59).  Whether PAS IV spans the lipid 
bilayer,  however,  cannot  be  determined  from  these  data. 
Topological labeling studies and amino acid sequence work 
will be required to answer this question. 
The carbohydrate composition of PAS IV appears typical 
of glycoproteins with  complex-type and  also possibly high 
mannose oligosaccharide chains, N-linked to asparagine resi- 
dues (36, 66). The apparent absence of N-acetylglucosamine 
is  probably a  reflection of the  relative insensitivity of the 
analytical procedures for amino sugars.  Quite high levels of 
glucose were detected. Since glucose is not considered to be a 
common constituent of terminally processed glycoproteins, 
the presence of this sugar in PAS IV preparations may be the 
result of contamination, possibly from the cellulose ion-ex- 
change columns used for purification of the protein. 
GREENWALT AND  MATHER  Epithelialand EndothelialCell GIycoprotein  403 FIGURE 5  Localization of PAS IV and factor VIII antigen in lactating bovine mammary tissue by immunofluorescence microscopy. 
(a)  Distribution of  PAS IV determined  in  paraffin-embedded  tissue  using affinity-purified polyclonal antibody.  Both  capillary 
endothelial cells  (single arrowheads)  and the apical surfaces of secretory-epithelial cells  (double arrowheads)  are  positive. (b) 
Distribution of PAS IV determined  in acetone-fixed, frozen tissue  using monoclonal antibody E-I. A staining pattern similar to 
that in a is seen (apical surfaces, less well stained). (c and d) Adjacent sections of acetone-fixed frozen tissue stained with either 
antibody to factor VIII antigen, a marker  of capillary endothelial cells  (c), or monoclonal antibody E-I  to PAS IV (d). The same 
cells appear to be stained with either antibody. L  alveolar lumen. Bars, 50/~m. (a) x  525; (b) x  350; (c) x  400; (d) x  450. 
Sialic acid constitutes ~4 mol/mol of  protein and variations 
in the level of this component may give rise to the isoelectric 
variants identified. Considering the amino acid composition, 
the desialylated protein is surprisingly basic, with isoelectric 
points over pH 9.0.  Lysine and arginine together only ap- 
proximately equal the  number of glutamate and  aspartate 
residues.  This suggests that the amino acids with acidic side 
chains are present in the native protein as the amides, gluta- 
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mine and asparaglne, respectively. From practical considera- 
tions, this cannot be determined from the amino acid analysis 
presented in Table I. 
The apparent M, of purified PAS IV was 76,000, the same 
as the antigen detected in unfractionated MFGM  or crude 
microsomal membranes isolated from lactating bovine mam- 
mary tissue.  Since we used exogenous proteinases during the 
purification of PAS IV, this immunoblotting data established FIGURE 6  Localization of PAS IV in bovine heart, intestinal smooth muscle, liver, and lung by immunofluorescence microscopy. 
(a) Distribution of PAS IV determined in acetone-fixed, frozen heart tissue using monoclonal antibody E-I. Capillary endothelial 
cells throughout the section are stained.  (b) Distribution of PAS IV determined in a paraffin-embedded section of smooth muscle 
from  the  small  intestine  using affinity-purified polyclonal antibody.  Capillary endothelial cells are  stained.  Specimen  shows 
capillaries sectioned in both the longitudinal (single arrowheads)  and transverse  planes.  (c) Distribution of PAS IV in acetone- 
fixed,  frozen  liver  using monoclonal  antibody  E-I,  showing specific  staining of  sinusoidal cells.  (d)  Distribution of  PAS  IV 
determined in a paraffin-embedded section of lung tissue using affinity-purified antibody. Only the apical surfaces of epithelial 
cells of bronchioles are stained. Capillary endothelial cells in the lung did not stain with either monoclonal or polyclonal antibodies. 
Bar, 50 p.m. (a and c) x  350; (b and d) x  400. 
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Summary of Distribution of PAS IV Determined by Immunofluorescence  Microscopy 
Tissue 
Staining patterns 
Monoclonal antibody E-l, frozen tissues 
Affinity-purified polyclonal antibody, paraffin- 
embedded tissues 
Mammary gland 
Heart 
Spleen 
Intestinal smooth 
muscle 
Liver 
Salivary gland 
Pancreas 
Mucosa of small 
intestine 
Lung 
Kidney 
Brain 
Endothelia and apical surfaces of secretory 
epithelial cells 
Endothelia 
Endothelia 
Endothelia 
Endothelia 
Endothelia 
Endothelia 
Endothelia 
Apical surfaces of the bronchiolar epithelial cells. 
Endothelia  negative. 
Particulate staining within cells of the distal 
convoluted tubules. Endothelia  negative. 
Negative 
Same 
Same 
Same 
Same 
Negative 
Negative 
Occasional  weak staining of the apical surfaces 
of acinar epithelial cells. Endothelia  negative. 
Occasional weak staining of epithelial cells of 
the crypts.  Endothelia positive. 
Same 
Negative 
Same 
the important point that our purified preparations did not 
consist of an artifactually produced peptide with an Mr coin- 
cident with that of the MFGM form of PAS IV.  However, 
the observation that Na2CO3-washed, plasmalemma-enriched 
fractions from mammary tissue also contain an immunoreac- 
tive protein of slightly higher Mr implies that the native form 
of PAS  IV  may have an Mr from  80,000 to  85,000.  The 
protein of Mr  =  76,000  in  MFGM  may therefore be the 
product of  limited proteolysis, either during or after secretion. 
In mammary secretory epithelium, PAS IV is present in 
high concentrations at the apical pole of the cells. This was 
expected because MFGM is known to be derived largely from 
apical plasma membrane during the secretion of milk triac- 
ylglycerols (2, 21,  61).  Whether this glycoprotein is also ex- 
pressed on basolateral membranes remains uncertain. Weak 
but apparently specific immunofluorescence was  often seen 
on all surface domains of the secretory cells, in contrast to 
antibodies specific for other MFGM constituents which ap- 
pear to only decorate apical surfaces (references 4, 20, 21, and 
31  and V. G. Johnson, D. E. Greenwalt and I.  H. Mather, 
unpublished observations). 
The most significant observation in this present study was 
the localization of PAS IV in capillary endothelial cells of 
many tissues, including the mammary gland. Unlike xanthine 
oxidase, which is also located in both capillary cells and .the 
MFGM (1 l, 40), PAS IV is a glycoprotein and firmly bound 
to membranes. From the immunoblotting data described in 
this study and other work (40, 54), it is obvious that PAS IV 
and xanthine oxidase are unrelated. Nor is this glycoprotein 
related to secretory component, lactoferrin, or lactoperoxi- 
dase, all proteins present in bovine whey and with molecular 
weights similar to that of PAS IV (l 3, 29, 30). 
We considered the possibility that PAS IV is one of the 
other well-characterized markers  of endothelial cells  previ- 
ously described in the literature. Endothelial cells are known 
to express a number of antigens including a serum albumin- 
binding  glycoprotein (67),  complement  Clq  receptors (3), 
factor VIII/von Willebrand factor (39, 41),  angiotensin-con- 
verting enzyme (5,  15), thrombospondin (57), thrombomod- 
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ulin (18), plasminogen activators (48), and lipoprotein lipase 
(38,  53,  69).  By  the  criteria  of molecular  size,  chemical 
composition, or tissue  distribution,  PAS  IV  appears to be 
distinct from any of these antigens. This glycoprotein also 
appears to be different from less well characterized endothelial 
cell antigens defined by either monoclonal antibodies (17, 42, 
62) or labeling techniques (73). Nor are the properties of PAS 
IV  similar to the class  I  or class  II  antigens  of the  major 
histocompatibility complex (58) which are also expressed on 
capillary endothelial cells (25, 60, 64, 65) and, in the case of 
the HLA-DR and Ia antigens, on human MFGM (76) and 
rodent mammary cells (45),  respectively. The apparent ab- 
sence of PAS IV from the surface of peripheral blood cells 
also argues against this possibility. 
PAS IV therefore appears to be a distinct membrane-bound 
antigen which  is  expressed in capillary endothelial cells  in 
certain tissues  and  on the  apical  surfaces of the  secretory 
epithelium of mammary cells and the bronchiolar epithelium 
of  lung. The dual location of  PAS IV in both exposed external 
epithelial surfaces in mammary gland and lung, and in cap- 
illary endothelial cells in many tissues, might imply that this 
glycoprotein has some protective function in the *overall de- 
fense of the host against disease.  Several of the previously 
recognized antigens of capillary endothelial cells are compo- 
nents of the immune system (3, 60, 64, 65). The function and 
identity of PAS IV, however, remains unknown. 
Expression of PAS IV in capillary endothelial cells appears 
to vary between tissues. Capillaries of mammary gland, heart, 
liver,  salivary gland,  spleen,  pancreas,  or intestine contain 
variable levels of the antigen. However, the endothelial cells 
of kidney, brain, lung, or large blood vessels are apparently 
unreactive with either monoclonal or polyclonal antibody. 
These observations are consistent with the general hypothesis 
that endothelial cells from different tissues  express different 
levels and complements of proteins and that these differences 
reflect the distinctive origins of capillary cells in embryonic 
tissues during development (5). 
There is a  current need for markers of capillary cells  in 
tissues.  Many  of the  known  endothelial  proteins  are  not specific for capillary cells,  are of uncertain specificity,  or are 
present in relatively low quantities and are not readily avail- 
able for study. The widely used capillary marker factor VIII/ 
yon Willebrand factor (39, 41) is a soluble protein present in 
megakaryocytes and platelets as well as associated with Wei- 
bel/Palade bodies in endothelial cells and in the extracellular 
matrix  (33).  To  our  knowledge,  the  only  other  practical 
marker that is commercially available is the lectin from Ulex 
europaeus (32) which  binds to certain  fucosyl  residues.  But 
this lectin binds to at least three different proteins in human 
umbilical  vein  endothelial  cells  (34)  and  is  unlikely  to  be 
specific for capillary cells. 
Specific  membrane  protein  markers for endothelial  cells, 
such as PAS IV, could be used for studies on the origin and 
development of organs during embryogenesis,  for studies on 
the relationship between parenchymal cells and the capillary 
bed in different tissues, and for studies of angiogenesis in solid 
tumors. Since an immunologically similar protein to PAS IV 
is present in human breast milk, this giycoprotein may prove 
to be useful as a marker of capillary cells in human tissues. 
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